Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Empower Clinics Inc EPWCF

Empower Clinics Inc. is a Canada-based integrated healthcare and medical device company with multi-disciplinary clinics. The Company provides body and mind wellness for patients through its medical clinics, digital and telemedicine care, medical diagnostics laboratories, and sale of medical devices. Its segments include Health & Wellness, comprising clinic operations, patient visits, and telemedicine services; Diagnostics & Technology, comprising the diagnostic testing services provided by Kai Medical, and the sale of medical equipment by Kai Medical Canada Corp. and MediSure; and Corporate. It is focused on offering clinical trial services, such as clinical trial design, patient recruitment, data management and regulatory compliance for the pharmaceutical, biotechnology and medical device industries. It has two clinical research sites in Dallas, Texas, becoming a site management organization (SMO) with six principal investigators (PI) with multiple clinical trials under application.


GREY:EPWCF - Post by User

Post by Smokey1958on Jun 20, 2022 11:24am
422 Views
Post# 34768838

The Foot is Finally Past the Door

The Foot is Finally Past the Door

With the NR today, Medisure has finally got a small footprint across the door and into the US market. With a population size 10x that of Canada it seems safe to assume that with FDA approval of its products and an annual run rate that should be above $2 million here in Canada ( let's see these financials over the next two weeks Steve) that a reasonable forecast for Medisure's combined annual revenues in both countries could well exceed $20 million. 

This won't happen overnight but for those holding patiently this may be one of the most promising longterm possibilities finally nearing fruition. Will the second half of 2022 see Empower back on track?

GLTE!!!

<< Previous
Bullboard Posts
Next >>